W135 Meningococcal Disease in Africa

Emerging Infectious Diseases

Volumn 9, Issue 11, 2003, Pages 1503-1504

  Pollard, Andrew J ^a   Santamaria, Maria ^b   Maiden, Martin C J ^a   Nicolas, P ^c   Handford, S ^d   Issa, M ^k   Longworth, E ^d   Jacobsson, S ^e   Parent du Chatelet, I ^f   Koumare, B ^g   Soriano Gabarro, M ^k   Achtman, M ^h   Greenwood, B ⁱ   LaForce, M ^j  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c WHO   (France)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e National Reference Laboratory for Pathogenic Neisseria   (Sweden)

^f Assoc pour la Medecine Preventive   (France)

^g WHO Intecountry Team   (Côte d’Ivoire)

^h MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^j Meningits Vaccine Project   (France)

^k Max Planck Inst for Infect Biology ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

AFRICA; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; CONFERENCE PAPER; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; TREATMENT OUTCOME; VACCINATION;

EID: 0242323649     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0911.020727     Document Type: Conference Paper

References (0)